Home > Healthcare > Drug Device Combination > Therapeutic Systems > Anal Fistula Treatment Market

Anal Fistula Treatment Market Size

  • Report ID: GMI8425
  • Published Date: Mar 2024
  • Report Format: PDF

Anal Fistula Treatment Market Size

Anal Fistula Treatment Market size was valued at around USD 728.5 million in 2023 and is estimated to grow at a CAGR of 4.4% between 2024 to 2032. This robust market growth can be attributed to factors such as the increasing prevalence of inflammatory bowel diseases, the rising incidence of anal fistulas, and the growing aging population.

 

The rising prevalence of inflammatory bowel diseases, including conditions such as Crohn's disease and ulcerative colitis, has led to an increased number of anal fistula cases around the world. For instance, according to a study published by Crohn’s and Colitis UK, in 2022, it was found that over half a million people in the country in UK have either Crohn's disease or ulcerative colitis. The chronic inflammation and complications associated with inflammatory bowel diseases, particularly in the perianal region, elevate the likelihood of anal fistula formation. This increased risk contributes to the growing demand for anal fistula management and treatment.

 

Moreover, the growing aging population contributes significantly to the rise in anal fistula cases. As individuals age, they may be more prone to certain health conditions, including inflammatory bowel diseases and infections, which are known risk factors for the development of anal fistulas. This demographic trend amplifies the overall incidence of anal fistulas, driving demand for related medical interventions.
 

Anal fistula treatment refers to the medical interventions and therapeutic strategies employed to address a pathological condition characterized by an abnormal tract or passage connecting the anal canal or rectum to the skin surface around the anus. The treatment aims to manage symptoms, promote healing, and prevent recurrence by addressing the underlying causes.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Anal fistula treatment industry reached USD 728.5 million in revenue in 2023 and is set to expand at 4.4% CAGR over 2024-2032 attributed to the increasing prevalence of inflammatory bowel diseases, and the growing aging population.

The surgical segment generated more than USD 328 million in 2023 and is estimated to record substantial growth through 2032 owing to the increasing adoption of surgical treatments in minimizing symptomatic discomfort associated with anal fistulas.

North America anal fistula treatment industry accounted for USD 295 million in revenue in 2023 and is set to exhibit robust growth through 2032 driven by the robust healthcare infrastructure, extensive R&D initiatives, and a high prevalence of inflammatory bowel diseases across the region.

Some of the leading firms engaged in the anal fistula treatment industry are AbbVie, Becton, Dickinson, and Company, Biolitec AG, Boston Scientific Corporation, Coloplast Group, Cook Medical, Gem srl, KARL STORZ SE & Co. KG, Medtronic plc, Teleflex Incorporated, and Zydus Lifesciences Limited.

Anal Fistula Treatment Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 307
  • Countries covered: 22
  • Pages: 180
 Download Free Sample